NSE: DRREDDY
DR. REDDY S LABORATORIES
Price history
+16.88% over 3M
Performance
52-week range
Position in day range
DRREDDY stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Sideways
50-DMA ₹1,202.51
RSI (14)
84
Overbought zone
Volatility (ATR)
2.42%
Moderate
Close streak
2d up
Volume vs 20d avg
0.70x
From 52W high
-4.45%
Up from 52W low
+22.80%
Green days (20)
13/20
Monthly seasonality
Average monthly move for DRREDDY across the available price history.
Key statistics
Open
1,345
Day high
1,363.7
Day low
1,345
Prev close
1,345
Volume
17.14 L
Avg vol (20d)
24.50 L
52W high
1,414.9
52W low
1,101
DRREDDY quarterly results
All DRREDDY results →Next results date
Awaiting intimation
Last results date
23 Oct 2026
Reports published
1 quarter covered
Revenue
₹8,671 cr
-1.5% YoY
Net profit
₹925 cr
-35.6% YoY
Operating profit
₹1,281 cr
-29.5% YoY
EPS
₹11.11
— YoY
Swipe sideways to see all columns →
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q2 FY272026-09-30 | ₹8,671 cr | ₹1,281 cr | ₹925 cr | 14.8% | 10.7% | ₹11.11 | -35.6% | +108.6% |
| Q1 FY272026-06-30 | ₹8,071 cr | ₹303 cr | ₹444 cr | 3.8% | 5.5% | ₹5.32 | — | +100.8% |
| Q4 FY262026-03-31 | ₹7,516 cr | ₹82.9 cr | ₹221 cr | 1.1% | 2.9% | ₹2.65 | — | -81.7% |
| Q3 FY262025-12-31 | ₹8,727 cr | ₹1,433 cr | ₹1,210 cr | 16.4% | 13.9% | ₹14.53 | — | -15.8% |
| Q2 FY262025-09-30 | ₹8,805 cr | ₹1,818 cr | ₹1,437 cr | 20.6% | 16.3% | — | — | — |
| TTM (last 4 quarters) | ₹32,984 cr | ₹3,100 cr | ₹2,799 cr | 9.4% | 8.5% | ₹33.61 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Dr. Reddy's Laboratories Limited Q2 FY27 Results: Net Profit ₹913 cr, Revenue from operations ₹8,698 cr
Dr. Reddy's Laboratories Limited (DRREDDY) reported Consolidated Q2 FY27 revenue from operations of ₹8,698 cr and net profit of ₹913 cr. Official figures, comparisons and disclosure details.
Dr. Reddy S Laboratories Opens Gap-Up at ₹1,163.70 — Should Investors Read This as a Trend or a One-Day Move?
Dr. Reddy S Laboratories (DRREDDY) trades at ₹1,145.00, -20.50 (-1.79%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Dr. Reddy S Laboratories Share Price Opens Gap-Up at ₹1,163.70: What Is Driving DRREDDY Today, and the Levels That Matter
Dr. Reddy S Laboratories (DRREDDY) trades at ₹1,145.00, -20.50 (-1.79%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Latest market news
Quarterly Results Lead Market Newsroom Heatmap on 31 October 2026
Quarterly results dominate financial newsrooms with 37 headlines across four major publishers on 31 October 2026, followed closely by industry trends, telecom, and technology shifts.
PB Fintech Limited Q2 FY27 Results: Net Profit ₹192 cr
PB Fintech Limited Q2 FY27 consolidated results: revenue from operations of ₹2,178 cr and net profit of ₹192 cr.
Reliance Industries Limited Q2 FY27 Results: Net Profit ₹29,550 cr
Reliance Industries Limited Q2 FY27 consolidated results: revenue from operations of ₹3,32,861 cr and net profit of ₹29,550 cr.
The Phoenix Mills Limited Q2 FY27 Results: Net Profit ₹127 cr
The Phoenix Mills Limited Q2 FY27 standalone results: revenue from operations of ₹141 cr and net profit of ₹127 cr.
Dixon Technologies (India) Limited Q2 FY27 Results: Net Profit ₹411 cr
Dixon Technologies (India) Limited Q2 FY27 consolidated results: revenue from operations of ₹21,794 cr and net profit of ₹411 cr.
Bank Of Baroda Q2 FY27 Results: Net Profit ₹6,532 cr
Bank Of Baroda Q2 FY27 standalone results: revenue from operations of ₹35,085 cr and net profit of ₹6,532 cr.
Price and history data from NSE via Upstox. For information only, not investment advice.